Neuroscience
Elan to create research centre with Cambridge University
DUBLIN
Sun Nov 27, 2011 4:14am EST
"(Reuters) - Elan Corp Plc has signed an agreement with Britain's Cambridge University to create a research center focused on therapies for Alzheimer's and Parkinson's, the Dublin-headquartered biotech group said on Sunday."
Read the full article
Addendum (28 November 2011):
From Cambirdge Business Media:
28 November 2011 12:32
$10m neuroscience drug discovery centre for Cambridge
Lautaro Vargas
Read the full article
- Congratulations Dr. Trevor Robbins!
Cambridge University figures in New Year Honours list The Cambridge Student Online 31 December 2011 [snip] "A CBE is awarded to another medical man, Professor Trevor Robbins, "for services to Medical Research". Professor Robbins is Head of the Department...
- Cognitive Enhancing Drugs
From The University of Cambridge: The Ethics of Smart Drugs 31 October 2011 Read the full article here...
- Neurodegenerative Disease Drug Discovery: Ucsf And Genentech
From Fierce Biotech: UCSF enters drug discovery agreement with Genentech Posted February 19, 2010 "The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover...
- Business World: Biogen Idec, Elan, & Tysabri (natalizumab) And Avonex (interferon Beta-1a)
From: RTE Ireland:Elan releases Tysabri trial figures July 19, 2005 11:09 Pharmaceutical company Elan has released figures showing that its suspended Tysabri drug improved the effectiveness of Biogen's Avonex in the treatment of multiple sclerosis....
- Business World: Biogen Idec, Elan, & Tysabri (natalizumab) (cont.)
Additional information in follow-up to this morning's Boston Globe report, from Bloomberg:Elan, Biogen Decline on Report of New Tysabri Illness June 2 (Bloomberg) -- Shares of Elan Corp. and Biogen Idec Inc. tumbled after a fourth possible case of...
Neuroscience
Elan and University of Cambridge to Create Neurodegenerative Research Institute
Elan to create research centre with Cambridge University
DUBLIN
Sun Nov 27, 2011 4:14am EST
"(Reuters) - Elan Corp Plc has signed an agreement with Britain's Cambridge University to create a research center focused on therapies for Alzheimer's and Parkinson's, the Dublin-headquartered biotech group said on Sunday."
Read the full article
Addendum (28 November 2011):
From Cambirdge Business Media:
28 November 2011 12:32
$10m neuroscience drug discovery centre for Cambridge
Lautaro Vargas
Read the full article
- Congratulations Dr. Trevor Robbins!
Cambridge University figures in New Year Honours list The Cambridge Student Online 31 December 2011 [snip] "A CBE is awarded to another medical man, Professor Trevor Robbins, "for services to Medical Research". Professor Robbins is Head of the Department...
- Cognitive Enhancing Drugs
From The University of Cambridge: The Ethics of Smart Drugs 31 October 2011 Read the full article here...
- Neurodegenerative Disease Drug Discovery: Ucsf And Genentech
From Fierce Biotech: UCSF enters drug discovery agreement with Genentech Posted February 19, 2010 "The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover...
- Business World: Biogen Idec, Elan, & Tysabri (natalizumab) And Avonex (interferon Beta-1a)
From: RTE Ireland:Elan releases Tysabri trial figures July 19, 2005 11:09 Pharmaceutical company Elan has released figures showing that its suspended Tysabri drug improved the effectiveness of Biogen's Avonex in the treatment of multiple sclerosis....
- Business World: Biogen Idec, Elan, & Tysabri (natalizumab) (cont.)
Additional information in follow-up to this morning's Boston Globe report, from Bloomberg:Elan, Biogen Decline on Report of New Tysabri Illness June 2 (Bloomberg) -- Shares of Elan Corp. and Biogen Idec Inc. tumbled after a fourth possible case of...